Advanced Targeted Therapy & Surgical Care by Dr. Lovedeep Singh Chauhan
Inflammatory Breast Cancer (IBC) is one of the most aggressive and rapidly progressing forms of breast cancer. Unlike typical breast cancers that present as a distinct lump, IBC often appears with sudden redness, swelling, warmth, and thickening of the skin over the breast. Because of its unique presentation and fast progression, early diagnosis and structured, evidence-based treatment are essential.
Under the care of Dr. Lovedeep Singh Chauhan , Consultant Surgical Oncologist in punjab at Max Super Speciality Hospital, Mohali, patients receive comprehensive, multidisciplinary management tailored to the biology and stage of the disease. Treatment of inflammatory breast cancer requires coordination between medical oncology, surgical oncology, radiation oncology, radiology, and pathology to achieve optimal outcomes.
Understanding Inflammatory Breast Cancer
Inflammatory Breast Cancer is a rare subtype of invasive breast cancer that accounts for approximately 1–5% of all breast cancer cases but contributes disproportionately to breast cancer-related mortality. The disease is characterized by cancer cells blocking lymphatic vessels in the skin of the breast. This blockage results in visible inflammation-like changes.
Unlike other breast cancers that grow as a localized mass, IBC spreads quickly within the breast tissue and skin. For this reason, it is usually diagnosed at Stage III (locally advanced) or Stage IV (metastatic).
Why Is It Called “Inflammatory”?
The term “inflammatory” does not mean the cancer is caused by infection. Rather, the redness and swelling resemble inflammation. The underlying mechanism involves tumor cells obstructing dermal lymphatics, leading to fluid accumulation and skin thickening.
How Inflammatory Breast Cancer Differs from Other Breast Cancers
Inflammatory Breast Cancer differs from more common types such as Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Awareness and clinical suspicion are critical due to its unique presentation.
No Palpable Lump
Unlike other breast cancers, IBC often does not present with a distinct lump.
Rapid Progression
IBC progresses over weeks to months rather than years like common breast cancers.
Diffuse Skin Changes
Causes redness, swelling, and thickening across the breast skin, not a localized mass.
Advanced Stage Diagnosis
IBC is typically diagnosed at Stage III or IV due to its aggressive nature.
Neoadjuvant Chemotherapy
Treatment usually begins with chemotherapy before surgery to shrink tumors.
Symptoms of Inflammatory Breast Cancer
Symptoms usually develop rapidly and may be mistaken for infection (mastitis), especially in younger women. If breast redness does not improve after a short course of antibiotics, further evaluation by a breast cancer specialist is mandatory.
Common Symptoms
- Redness covering one-third or more of the breast
- Swelling and heaviness
- Skin thickening with “orange peel” (peau d’orange) appearance
- Warmth over the breast
- Tenderness or burning sensation
- Flattened or inverted nipple
- Enlarged lymph nodes in the armpit or near the collarbone
- Sudden increase in breast size
Causes & Risk Factors
- Female gender (rare but possible in males)
- Younger age compared to other breast cancers
- Obesity
- Genetic mutations such as BRCA1 or BRCA2
- Family history of breast cancer
IBC may be more common in younger patients compared to other breast cancer subtypes, making clinical vigilance especially important.
Diagnostic Evaluation and Staging
Accurate diagnosis involves a combination of clinical examination, imaging, tissue confirmation, molecular testing, and staging.
Clinical Examination
A detailed breast and lymph node examination helps identify typical skin changes and nodal involvement.
Biopsy
- Core needle biopsy confirms malignancy
- Skin punch biopsy may be required to demonstrate dermal lymphatic invasion
Imaging Studies
- Mammography
- Breast ultrasound
- MRI breast (local extent assessment)
- PET-CT scan (for distant metastasis evaluation)
Molecular Testing
- Estrogen receptor (ER)
- Progesterone receptor (PR)
- HER2 status
- Ki-67 proliferation index
These markers determine systemic therapy decisions.
Staging
- Stage III: Locally advanced disease involving skin and nodes
- Stage IV: If distant metastasis is present
Staging determines prognosis and guides treatment planning.
Treatment Strategy for Inflammatory Breast Cancer
Inflammatory Breast Cancer requires multimodal treatment. Surgery alone is not adequate. The standard approach includes neoadjuvant chemotherapy, surgery, radiation therapy, and targeted or hormonal therapy when indicated.
Multimodal Treatment
- Neoadjuvant chemotherapy
- Surgery
- Radiation therapy
- Targeted therapy or hormonal therapy when indicated
This sequence is critical for improving outcomes.
Neoadjuvant Chemotherapy – The First Step
- Reduces tumor burden
- Treats microscopic systemic disease
- Improves surgical resectability
- Provides information about tumor response
Patients with HER2-positive disease receive targeted anti-HER2 therapy alongside chemotherapy. Hormone receptor-positive tumors may require endocrine therapy later. Response assessment after chemotherapy determines the timing and feasibility of surgery.
Surgical Management of Inflammatory Breast Cancer
Surgery is performed after completion of neoadjuvant chemotherapy and adequate response evaluation. Under the expertise of Dr. Lovedeep Singh Chauhan at Max Super Speciality Hospital, Mohali, surgery is performed following strict oncologic principles to maximize safety and disease control.
Modified Radical Mastectomy
- Removal of the entire breast
- Removal of axillary lymph nodes
- Clear surgical margins
Breast-conserving surgery is generally not recommended due to the diffuse nature of the disease.
Lymph Node Management
Complete axillary lymph node dissection is performed to remove involved nodes and reduce recurrence risk.
Reconstruction Considerations
Immediate reconstruction is usually deferred because radiation therapy is mandatory after surgery. Delayed reconstruction options may be discussed once treatment is completed.
Radiation, Targeted, and Hormonal Therapy in IBC
Post-surgical therapies play a critical role in improving long-term outcomes and reducing recurrence in Inflammatory Breast Cancer.
Role of Radiation Therapy
- Essential component of treatment following mastectomy
- Targets residual microscopic disease in the chest wall and regional lymph nodes
- Significantly improves long-term disease control in IBC
Targeted & Hormonal Therapy
- HER2-Positive IBC: HER2-targeted therapies improve survival outcomes
- Hormone Receptor Positive IBC: ER/PR-positive tumors receive hormonal therapy for several years
- These therapies reduce recurrence risk and improve overall survival
Prognosis and Survival
While inflammatory breast cancer is aggressive, advancements in systemic therapy, targeted therapy, and multidisciplinary coordination have significantly improved outcomes over the last decade.
Stage at diagnosis
Tumor biology
Response to chemotherapy
Completeness of surgery
Patient’s overall health
Early diagnosis and adherence to structured treatment protocols are critical for achieving optimal results.
Recovery and Follow-Up Care
Post-treatment care is crucial to monitor recovery, prevent complications, and detect any recurrence early.
Scheduled Follow-Up Visits
Physical Examination & Imaging
Monitoring for Recurrence
Lymphedema Prevention & Physiotherapy
Nutritional Counseling
Psychological Support
Long-term surveillance ensures early detection of recurrence and effective management of treatment-related side effects.
Why Choose Dr. Lovedeep Singh Chauhan for Inflammatory Breast Cancer Treatment?
Inflammatory breast cancer requires experience, precision, and coordination. Dr. Chauhan is a Consultant Surgical Oncologist with advanced training in breast cancer management and complex oncologic surgery.
Specialized Expertise in Breast Oncology
- Evidence-based surgical planning
- Modified Radical Mastectomy with meticulous technique
- Axillary lymph node dissection
- Multidisciplinary tumor board coordination
Multidisciplinary Cancer Care
Treatment is delivered through collaboration with medical oncologists, radiation oncologists, radiologists, and pathologists to ensure seamless, coordinated care.
Advanced Infrastructure
- Advanced imaging facilities
- Modern chemotherapy units
- Radiation oncology services
- Dedicated oncology ICU support
- Comprehensive cancer care environment
Patient-Centered Approach
- Detailed explanation of diagnosis and staging
- Transparent discussion of treatment steps
- Ethical, guideline-based recommendations
- Continuous follow-up and survivorship planning
Focus is on achieving the best oncologic outcome while preserving quality of life.
When Should You Seek Consultation?
Immediate evaluation is necessary if you notice:
Sudden breast redness and swelling
Skin thickening or dimpling
Rapid increase in breast size
Symptoms not improving with antibiotics
Newly diagnosed locally advanced breast cancer
Early specialist involvement can significantly influence survival and treatment success.
Have a Question? Get In Touch
